socalTECH

APRIL 25, 2017

Los Angeles-based TeleSign , which uses phone calls and related information for mobile identity management, authentication, and other cloud services, has been acquired by Brussels-based BICS , in a deal worth $230M in cash plus unspecified earnout. BICS said that TeleSign has annual revenues of around $100M. As part of the deal, BICS said that TeleSign will continue to operate independently as a wholly-owned subsidiary of the company, led by current CEO Aled Miles.

Mobile 247

Mobile Los Angeles Sites Services 247

L.A. Business Journal

APRIL 25, 2017

TeleSign Corp. of Marina del Rey, a developer of user authentication software, announced on Tuesday that it had agreed to be acquired for $230 million in cash by telecommunications company BICS of Belgium.

Marina Del Rey 189

Marina Del Rey Company Companies Software 189

socalTECH

APRIL 25, 2017

Irvine-based cybersecurity firm CrowdStrike appears to be the latest victim of unsubstantiated "facts" from the current White House administration, as President Trump inferred that the company, incorrectly, is owned by a "very rich Ukrainian". The company is actually backed by Google Capital, Rackspace, Accel Partners, and Warburg Pincus. CrowdStrike's founder is George Kurtz, who founded Irvine's Foundstone, and later sold it to McAfee.

IBM 189

IBM IBM Google Activity 189

SoCal CTO

APRIL 25, 2017

Here is the most recent version of an all too common email inquiry from a startup founder. I've removed the two words that described the market - otherwise this is verbatim. I'm working on a start up idea in the XXX market with my partner and we are currently looking for full stack developer to join us as a technical co-founder. We have been reading about the LA CTO Forum and we thought it would be a great place to find him/her.

Email 150

Email Startup Develop Development 150

Advertiser: Aggregage

Office leases are one of companies’ largest expenses, and if your whole team is working from home with no clear end in sight, you may be wondering what to do about your lease.

Company

socalTECH

APRIL 25, 2017

San Diego-based Forge Therapeutics , a biotechnology startup developing antibiotics, said on Tuesday that it has raised $15M in a Series A funding. The funding was led by MagnaSci Ventures, along with Evotec AG, Alexandria Venture Investments, MP Healthcare Venture Management, Red Apple Group, and WS Investments. MagnaSci Ventures's Brian Dorsey joins the company's board along with the funding.

San Diego 138

San Diego Invest Funding Startup 138

L.A. Business Journal

APRIL 25, 2017

Belgium telecommunications company BICS to buy TeleSign for $230 million, in-home clinical trial software startup Science 37 raises $29 million, and Soylent recalls powder after accidental mixing with whey.

Company 113

Company Companies Report Software 113

Xconomy

APRIL 25, 2017

Over the past 28 years or so, ResMed (NYSE: RMD ) has built an empire around its respiratory devices for managing sleep apnea and other forms of “sleep-disordered breathing.” In the fiscal year that ended last June, the San Diego maker of respiratory machines for maintaining continuous positive airway pressure (CPAP) generated over $1.8 billion in global sales.

San Diego 74

San Diego Sales Technology Marketing 74

socalTECH

APRIL 25, 2017

Los Angeles-based Rubicon Project is applying its programmatic advertising technology to digital jukeboxes, in a deal with connected, digital jukebox developer TouchTunes. According to the two, TouchTunes' "out-of-home" audience will be made available programmatically in a real-time buying marketplace powered by Rubicon's technology. The comapnies said TouchTunes has a reach and monthly audience of over 38 million unique visitors.

Advertising 124

Advertising Los Angeles Technology Angel 124

Xconomy

APRIL 25, 2017

One reason that drug-resistant “superbugs” are a growing healthcare problem is the hardiness of gram-negative bacteria, a type of bacteria whose characteristics render many antibiotics ineffective. Forge Therapeutics says it has found a way to target an enzyme found only in these bacteria, and potentially take them out. Now, the biotech firm is preparing to bring that technology into clinical trials.

San Diego 59

San Diego Invest Funding Technology 59

socalTECH

APRIL 25, 2017

Playa Vista-based Science 37 , which is developing technology and a model that allows pharmaceuticals companies and others to conduct clinical trials in patients' homes--rather than dedicated, off-site facilities--has raised $29M in a Series C funding round. The round was led by Glynn Capital Management, and also included GV (formerly Google Ventures), plus Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures.

Google 124

Google Research Capital Sites 124

socalTECH

APRIL 25, 2017

San Diego-based Heron Therpaeutics , a biotechnology firm developing treatments for pain, has named Robert E. Hoffman as its Chief Financial Officer and Senior, Vice President, Finance. Hoffman was recently serving as EVP and CFO of Innovus Pharmaceuticals for the last eight months, and also was recently CFO of AnaptysBio. Hoffman also has been at Arena Pharmaceuticals and Polaris Group, and is on the board of CombiMatrix, Kura Oncology, and MabVax Therapeutic Holdings.

San Diego 113

San Diego Develop Development 113

socalTECH

APRIL 25, 2017

Los Angeles-based online electronics retailer Newegg said this morning that it has linked with PingPong , a provider of secure payment services for Chinese sellers, to help make it easier for its Chinese sellers to collect payments from customers. Financial details of the link were not announced. The two said that PingPong's payment service helps Chinese sellers overcome the challenges of cross-border online sales.

NewEgg 113

NewEgg Services Los Angeles Sales 113

socalTECH

APRIL 25, 2017

Westlake Village-based Sienna Biopharmaceuticals , which is developing medical dermatology and aesthetics treatments, has raised $40M in a Series B funding. The funding was led by ARCH Venture Partners and Venvest Capital, and also included Partner Fund Management, Altitude Life Science Ventures, and Dr. David Pyott, plus new investors Fidelity Management & Research Company, certain investment funds advised by Clough Capital Partners L.P., Omega Fund Management, and others.

Westlake Village 113

Westlake Village Research Capital Funding 113